Surgical sealants and adhesives play a crucial role in
repairing and strengthening tissues after an injury and surgical wounds. They
form a chemical coating and prevent bleeding and oozing of bodily fluids. The
sealants and adhesives bind the external and internal helping them to heal
faster.
View summary of this report, Click Here
Cohera Medical recently announced that it has received
Investigational Device Exemption
(IDE) approval from the U.S.’s FDA (Food and Drug Administration) to start a
multicenter clinical trial for Sylys Surgical Sealant device. The company
claims that the revolutionary design will help reduce anastomotic leakage post
gastrointestinal surgeries.
Sylys
Surgical Sealant is a resorbable, elastic, and synthetic sealant. It is used
along with standard anastomotic closure method such as staples and sutures.
This sealant protects the sutures and supports them during the initial healing
days, when the chances of leaks are higher. The Sylys Surgical Sealant is meant
particularly for general, bariatric, and colorectal surgeries.
Another similar fibrin sealant is the EVARREST by
Ethicol. Ethicol recently announced that it received an approval from the FDA.
This flexible sealant patch is implanted with a new composition of human
biologics that provides durable mechanical structure for integrated clot
formation. This sealant could be the answer that surgeons were looking for.
They had been looking for a 1st attempt efficiency to reduce disturbances
and outcomes of challenging breeding.
This
sealant patch is meant to be used with manual compression as an adjunct to the
hemostasis in adult patients undergoing a surgery. It is used when the bleeding
cannot be controlled or is impractical using conventional techniques such as
sutures.
This
unique solvent does not require any preparation, moistening, or mixing with
refrigeration and saline. It also has shelf life of 30 months. It is placed
upon the bleeding wound or surface and a manual compression is added for a
couple of minutes. The sealant is bioabsorbable in around 8 weeks.
According to a new report by Grand View Research, Inc;
the surgical sealants and adhesives market is anticipated to reach USD 4.5
billion by 2025. Growing demand for surgical services and growing concerns to
reduce wounds caused by surgeries can drive the market.
Cohera
Medical, Inc.; CryoLife, Inc.; Ethicon, Inc. [J&J]; and Integra
LifeSciences Holdings Corporation emergence of new local players in the market
could increase competition.
Click Here For Access Full Report : https://goo.gl/pobPHP
ConversionConversion EmoticonEmoticon